Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Andrea Bozoki"'
Autor:
Emily W Paolillo, Kaitlin B Casaletto, Annie L Clark, Jack C Taylor, Hilary W Heuer, Amy B Wise, Sreya Dhanam, Mark Sanderson-Cimino, Rowan Saloner, Joel H Kramer, John Kornak, Walter Kremers, Leah Forsberg, Brian Appleby, Ece Bayram, Andrea Bozoki, Danielle Brushaber, R Ryan Darby, Gregory S Day, Bradford C Dickerson, Kimiko Domoto-Reilly, Fanny Elahi, Julie A Fields, Nupur Ghoshal, Neill Graff-Radford, Matthew G H Hall, Lawrence S Honig, Edward D Huey, Maria I Lapid, Irene Litvan, Ian R Mackenzie, Joseph C Masdeu, Mario F Mendez, Carly Mester, Toji Miyagawa, Georges Naasan, Belen Pascual, Peter Pressman, Eliana Marisa Ramos, Katherine P Rankin, Jessica Rexach, Julio C Rojas, Lawren VandeVrede, Bonnie Wong, Zbigniew K Wszolek, Bradley F Boeve, Howard J Rosen, Adam L Boxer, Adam M Staffaroni
Publikováno v:
JMIR Aging, Vol 7, p e52831 (2024)
BackgroundFrontotemporal lobar degeneration (FTLD) is a leading cause of dementia in individuals aged
Externí odkaz:
https://doaj.org/article/e3a85b9c842b435281a2a70b74fac8bf
Publikováno v:
Journal of Alzheimer's Disease Reports
Background: Postmortem studies of brains with Alzheimer’s disease (AD) not only find amyloid-beta (Aβ) and neurofibrillary tangles (NFT) in the visual cortex, but also reveal temporally sequential changes in AD pathology from higher-order associat
Publikováno v:
Trends Mol Med
Trajectories of cognitive decline vary considerably among individuals with mild cognitive impairment (MCI). To address this heterogeneity, subtyping approaches have been developed, with the objective of identifying more homogeneous subgroups. To date
Publikováno v:
Journal of Alzheimer's disease : JAD. 77(3)
Background: Postmortem studies of Alzheimer’s disease (AD) brains not only find amyloid-β (Aβ) and neurofibrillary tangles (NFT) in the primary and associative visual cortical areas, but also reveal a temporally successive sequence of AD patholog
Autor:
Yingjie Li, Alzheimer’s Disease Neuroimaging Initiative, Jongeun Choi, David C. Zhu, Liangliang Zhang, Chae Young Lim, Andrea Bozoki, Tapabrata Maiti
Publikováno v:
Statistical Methods in Medical Research. 28:2801-2819
With rapid aging of world population, Alzheimer’s disease is becoming a leading cause of death after cardiovascular disease and cancer. Nearly 10% of people who are over 65 years old are affected by Alzheimer’s disease. The causes have been studi
Publikováno v:
IEEE Journal of Translational Engineering in Health and Medicine
This paper proposes a robust method for the Alzheimer’s disease (AD), mild cognitive impairment (MCI), and normal control subject classification under size limited fMRI data samples by exploiting the brain network connectivity pattern analysis. Fir
Autor:
Mary Akinola, Milos D. Ikonomovic, Marc Agronin, Jiong Shi, Adrian Smith, Joel Ross, Craig Curtis, Michelle Zanette, Marwan N. Sabbagh, Stephen Salloway, Yavir M. Escovar, Dietmar Rudolf Thal, Teresa Villena, Jose Gamez, Upinder Singh, Ranjan Duara, Carl H. Sadowsky, Adam S. Fleisher, Thomas G. Beach, Gill Farrar, Rik Vandenberghe, Paul Sherwin, Kirk A. Frey, Zuzana Walker, Andrea Bozoki, Christopher Buckley, Arvinder Hunjan
Publikováno v:
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction Performance of the amyloid tracer [18F]flutemetamol was evaluated against three pathology standard of truth (SoT) measures including neuritic plaques (CERAD “original” and “modified” and the amyloid component of the 2012 NIA-AA g
Publikováno v:
Alzheimer's & Dementia. 12:1250-1258
Introduction We evaluated the effect of cerebral amyloid-β (Aβ) deposition in cognitively normal (CN) seniors on regional metabolism of specific brain regions known to be affected by p-tau deposition. Methods Fluorodeoxyglucose positron emission to
Publikováno v:
The Clinical Journal of Pain. 32:478-487
OBJECTIVES Facial expression may be a surrogate marker of pain in Alzheimer disease (AD) when self-report of pain is compromised. Recent studies have demonstrated increased pain sensitivity in AD; however, experimental pain studies analyzing facial e
Autor:
Roger Bullock, Adrian Ivanoiu, Clive Holmes, Marilyn S. Albert, Michelle Zanette, Christopher Buckley, Jose Gamez, Juha O. Rinne, Eric Salmon, G. Farrar, Ranjan Duara, Kirk A. Frey, Andrea Cherubini, Marc Agronin, Jiong Shi, Eric Triau, Carl H. Sadowsky, Paul Sherwin, Zuzana Walker, Beth Safirstein, Marwan N. Sabbagh, Paul Loughlin, David A. Wolk, Lennart Minthon, Richard Perry, Steen G. Hasselbalch, Peter Høgh, Adam S. Fleisher, Fraser Inglis, Andrea Bozoki
Publikováno v:
JAMA Neurology 75 (2018): 1114–1123. doi:10.1001/jamaneurol.2018.0894
info:cnr-pdr/source/autori:Wolk, David A.; Sadowsky, Carl; Safirstein, Beth; Rinne, Juha O.; Duara, Ranjan; Perry, Richard; Agronin, Marc; Gamez, Jose; Shi, Jiong; Ivanoiu, Adrian; Minthon, Lennart; Walker, Zuzana; Hasselbalch, Steen; Holmes, Clive; Sabbagh, Marwan; Albert, Marilyn; Fleisher, Adam; Loughlin, Paul; Triau, Eric; Frey, Kirk; Hogh, Peter; Bozoki, Andrea; Bullock, Roger; Salmon, Eric; Farrar, Gillian; Buckley, Christopher J.; Zanette, Michelle; Sherwin, Paul F.; Cherubini, Andrea; Inglis, Fraser/titolo:Use of Flutemetamol F18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment/doi:10.1001%2Fjamaneurol.2018.0894/rivista:JAMA Neurology/anno:2018/pagina_da:1114/pagina_a:1123/intervallo_pagine:1114–1123/volume:75
JAMA Neurology, Vol. 75, no. 9, p. 1114-1123 (2018)
info:cnr-pdr/source/autori:Wolk, David A.; Sadowsky, Carl; Safirstein, Beth; Rinne, Juha O.; Duara, Ranjan; Perry, Richard; Agronin, Marc; Gamez, Jose; Shi, Jiong; Ivanoiu, Adrian; Minthon, Lennart; Walker, Zuzana; Hasselbalch, Steen; Holmes, Clive; Sabbagh, Marwan; Albert, Marilyn; Fleisher, Adam; Loughlin, Paul; Triau, Eric; Frey, Kirk; Hogh, Peter; Bozoki, Andrea; Bullock, Roger; Salmon, Eric; Farrar, Gillian; Buckley, Christopher J.; Zanette, Michelle; Sherwin, Paul F.; Cherubini, Andrea; Inglis, Fraser/titolo:Use of Flutemetamol F18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment/doi:10.1001%2Fjamaneurol.2018.0894/rivista:JAMA Neurology/anno:2018/pagina_da:1114/pagina_a:1123/intervallo_pagine:1114–1123/volume:75
JAMA Neurology, Vol. 75, no. 9, p. 1114-1123 (2018)
Importance: Patients with amnestic mild cognitive impairment (aMCI) may progress to clinical Alzheimer disease (AD), remain stable, or revert to normal. Earlier progression to AD among patients who were β-amyloid positive vs those who were β-amyloi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b887517374fda290287c07b0622b9323